Prevention

SARS-CoV-2 is aerosolized. If a non-vaccinated person who is shedding the virus visits a vaccinated relative in a nursing home, he can easily spread the virus to all who reside in the facility.

That an entirely new outbreak of Ebola would be triggered by a latent infection 5 to 6 years after the initial infection is deeply worrisome.

COVID-19 outbreak hits Kentucky nursing home a week after CMS relaxes visiting restrictions.

The shape and material composition of the N95 respirators varied widely from manufacturer to manufacturer, which can result in variations in the efficacy of a particular method from one product to the next.

Investigators conclude that asymptomatic carriers increased the duration of the pandemic. Every patient should be tested for COVID-19.

Abby Basalely, MD: “The majority of children will recover from MIS-C and we see them thriving and doing well post hospitalization if they need hospitalization for the syndrome.”

The CMS update on when nursing home residents can have visitors raises grave concerns. The recommendation appears to assume that herd immunity is reached at 70%.

In CMS’ official announcement easing restrictions for visiting nursing homes, no mention was made of the year anniversary—marked today—of when the WHO officially labeled COVID-19 a global pandemic. Still, in so many words, the agency said enough is enough.

Yes, fully vaccinated people can relax some of the social distancing protocols that we’ve all been chaffing under this year. However, understand the nuances.

Difficulties in communicating with the elderly necessitate close speaking. These circumstances are a ripe atmosphere for spreading respiratory diseases. While residents were largely isolated from the broader population, their caretakers were not.

The CDC guidance states that persons past 2 weeks of their final COVID-19 vaccine dose face little risk from unmasked, non-distancing indoor visiting of unvaccinated, low-risk members from a single household.

Even with effective screening, treatment, and education, STIs can be like movie villains who just won’t die, who change form, and who keep coming back to wreak havoc. They’re relentless, but so is science.

Linda S. Estep, BS MT (ASCP), CIC: “I’ve done many hand hygiene audits in my day, I still do hand hygiene audits, when I’m in the hospitals now. If they know who you are, they scatter. They know the infection preventionists.”

There needs to be a shift from droplet precaution standards to airborne spread standards and we need to invest in the safety of our frontline workers.

The decision by Texas and other states to reopen seems to disregard the threat posed by COVID-19 variants, opponents of the move argue.

Infection prevention isn’t unique to health care, but rather representative of a bigger role within the community – it’s where health care and public health meet.

This may not be the best time to ask, “What’s next?” But…what’s next? What pathogen(s) not called COVID-19 should we be most concerned about? And where will it (they) be coming from?

Linda Spaulding RN, BC, CIC, CHEC, CHOP: “There have been 3,104,010 cases of COVID-19 among kids between the ages of zero and 20…. That means that 13.1% of all the cases of COVID-19 that we’ve seen in the US have been children.”

Twenty-six percent of people who are taking a wait-and-see approach about whether to get the COVID-19 vaccine say that they’d be more likely to get vaccinated if it involved just a single dose.

As more people become vaccinated, we will be navigating the aspects of a partially vaccinated public. This will be especially challenging as we learn more about prevention of infection and not just severe disease.

Kelly Cawcutt, MD, MS, FACP, FIDSA: “In a perfect world, vascular access teams and infection prevention teams really should be working very tightly together to optimize the practice of putting our vascular access in place.”

Investigators wanted to see how their method would fare against Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus, and results were promising.

Janssen Ad26.COV2.S is an intramuscular injection vaccine consisting of a replication-incompetent recombinant adenovirus type 26 (Ad26) vector which expresses the SARS-CoV-2 spike (S) protein.

An FDA ruling this week quickens the process by which COVID-19 vaccine manufacturers can get to the market—and into arms—booster shots that are targeted at variants.

Daniel Burnett, MD, MBA: “The aerosols, the things that are the true danger and that can hang in the air for hours, depending on their size, are still released around the edges and around the nose of cloth masks. A cloth mask does very little to protect you.”